Martin James Whitaker

Martin James Whitaker

Directeur/Membre du Conseil chez
D3 Pharma Ltd
50 ans
Health Technology
Consumer Services
Commercial Services

Profil

Martin James Whitaker is the founder of Faveo Ltd. He currently holds director positions at Diurnal Ltd. and D3 Pharma Ltd. Previously, he was the Chief Executive Officer & Executive Director at Diurnal Group Ltd. from 2012 to 2022.
He also held positions as Operations Director at Critical Pharmaceuticals Ltd., Business Manager at Fusion IP Ltd., and Head-Research & Development at Pfizer Ltd. Additionally, he served as a Non-Executive Director at PH Therapeutics Ltd. from 2013 to 2014.
Whitaker received his undergraduate degree from the University of Bristol and his doctorate from The University of Nottingham.

Postes actifs de Martin James Whitaker

SociétésPosteDébut
D3 Pharma Ltd
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 22/08/2012

Anciens postes connus de Martin James Whitaker

SociétésPosteFin
DIUL GROUP Directeur Général 04/04/2022
Directeur/Membre du Conseil 03/07/2014
Directeur Technique/Scientifique/R&D -
Fondateur -
FUSION IP PLC Corporate Officer/Principal -
Voir l'expérience en détail de Martin James Whitaker

Formation de Martin James Whitaker

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

13

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Commercial Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Consumer Non-Durables

Health Technology

Health Services

Health Technology

D3 Pharma Ltd

  1. Bourse
  2. Insiders
  3. Martin James Whitaker
🔇